tranylcypromine has been researched along with ketamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bruce, DL; Capan, L | 1 |
| Bartova, L; Kasper, S; Naderi-Heiden, A; Praschak-Rieder, N; Stamenkovic, M; Vogl, SE; Willeit, M | 1 |
| Bauer, M; Findeis, H; Ludwig, VM; Ritter, P; Rucker, J; Sauer, C; Young, AH | 1 |
3 other study(ies) available for tranylcypromine and ketamine
| Article | Year |
|---|---|
Antidepressants do not increase the lethality of ketamine in mice.
Topics: Amitriptyline; Animals; Drug Synergism; Ketamine; Lethal Dose 50; Mice; Tranylcypromine | 1983 |
Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Female; Humans; Inpatients; Ketamine; Monoamine Oxidase Inhibitors; Suicide Prevention; Tranylcypromine | 2015 |
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.
Topics: Administration, Intravenous; Adult; Aged; Antidepressive Agents; Blood Pressure; Cohort Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Rate; Humans; Injections, Subcutaneous; Ketamine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Retrospective Studies; Tranylcypromine; Young Adult | 2021 |